SCHEMBL869228

SCHEMBL869228

CC(N)c1ccc2[nH]c3ccccc3c2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 8/20 0.59
AHR P35869 1/20 0.53
KDM4E B2RXH2 3/20 0.50
ALDH1A1 P00352 2/20 0.50
HSD17B10 Q99714 2/20 0.50
KMT2A Q03164 2/20 0.50
MAPT P10636 2/20 0.50
GPR3 P46089 1/20 0.50
MEN1 O00255 1/20 0.50
HPGD P15428 1/20 0.50
GABRP O00591 2/20 0.45
GABRD O14764 2/20 0.45
GABRA1 P14867 2/20 0.45
GABRB1 P18505 2/20 0.45
GABRG2 P18507 2/20 0.45
GABRB3 P28472 2/20 0.45
GABRA5 P31644 2/20 0.45
GABRA3 P34903 2/20 0.45
GABRA2 P47869 2/20 0.45
GABRB2 P47870 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5497678 0.89 KIF11 (0.74) KIF11AHRKDM4EALDH1A1HSD17B10
SCHEMBL13010630 0.85 KIF11 (0.79) KIF11AHRKDM4EALDH1A1HSD17B10
SCHEMBL31549973 0.85 KIF11 (0.79) KIF11AHRKDM4EALDH1A1HSD17B10
SCHEMBL18364663 0.81 KIF11 (0.57) KIF11AHRKDM4EALDH1A1HSD17B10
SCHEMBL28363827 0.79 AHR (0.59) KIF11AHRKDM4EALDH1A1HSD17B10
SCHEMBL6484779 0.77 KIF11 (0.49) KIF11AHRKDM4EALDH1A1HSD17B10
SCHEMBL17779613 0.77 KIF11 (0.53) KIF11AHRKDM4EALDH1A1HSD17B10
SCHEMBL11067278 0.77 KMT2A (0.66) KIF11AHRKDM4EALDH1A1KMT2A
SCHEMBL28201526 0.76 AHR (0.55) KIF11AHRKDM4EALDH1A1HSD17B10
SCHEMBL27276829 0.76 KIF11 (0.65) KIF11AHRKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250201546-A1 METHOD FOR PROCESSING SUBSTRATE, KIT FOR PROCESSING SUBSTRATE, AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE TOKYO OHKA KOGYO CO., LTD. (JP) 2025-06-19 US disclosed
US-20250140548-A1 PROCESSING SOLUTION, METHOD FOR PROCESSING SUBSTRATE, AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE TOKYO OHKA KOGYO CO., LTD, (JP) 2025-05-01 US disclosed
US-20250140549-A1 PROCESSING SOLUTION, METHOD FOR PROCESSING SUBSTRATE, AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE TOKYO OHKA KOGYO CO., LTD, (JP) 2025-05-01 US disclosed
US-20250084351-A1 PROCESSING SOLUTION, METHOD FOR PROCESSING SUBSTRATE, AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE TOKYO OHKA KOGYO CO., LTD. (JP) 2025-03-13 US disclosed
EP-3066471-B1 METHODS FOR IMPROVING ANALYTE DETECTION USING PHOTOCHEMICAL REACTIONS ALLIED INNOVATIVE SYSTEMS LLC (US) 2020-04-01 EP disclosed
CN-109666656-A A method of CVI988 plants of marek's disease virus of purifying recombination chicken infectious bursal disease virus VP 2 gene 北京市农林科学院 2019-04-23 CN disclosed
EP-2825038-B1 ORGANSTORAGE SOLUTION COMPRISING (HYDROXY)ECTOINE BITOP AG (DE) 2017-10-11 EP disclosed
US-9499864-B2 Expression of FABP4 and other genes associated with bladder cancer progression AAB PATENT HOLDING APS (DK) 2016-11-22 US disclosed
EP-3066471-A1 METHODS FOR IMPROVING ANALYTE DETECTION USING PHOTOCHEMICAL REACTIONS Allied Innovative Systems, LLC (US) 2016-09-14 EP disclosed
WO-2015066577-A1 METHODS FOR IMPROVING ANALYTE DETECTION USING PHOTOCHEMICAL REACTIONS ALLIED INNOVATIVE SYTSTEMS, LLC (US) 2015-05-07 WO disclosed
WO-1991008753-A1 METHOD AND COMPOSITION FOR THE TREATMENT OF MAMMALIAN HIV INFECTION GESELLSCHAFT FÜR STRAHLEN- UND UMWELTFORSCHUNG MBH (GSF) (DE) 1991-06-27 WO disclosed
EP-0429587-A1 PROCESS FOR OBTAINING A REGULATION PROTEIN (NEF) FOR HIV-1 USING THE HUMAN CELL LINE TH4-7-5. GSF GES FUER STRAHLEN UND UMWE (DE) 1991-06-05 EP disclosed
EP-0428656-A1 HUMAN CELL LINE LC5 AND ITS USE. STRAHLEN UMWELTFORSCH GMBH (DE) 1991-05-29 EP disclosed
WO-1990015150-A1 PROCESS FOR OBTAINING A REGULATION PROTEIN (NEF) FOR HIV-1 USING THE HUMAN CELL LINE TH4-7-5 GSF GESELLSCHAFT FÜR STRAHLEN- UND UMWELTFORSCHUNG MBH (DE) 1990-12-13 WO disclosed
WO-1990014419-A1 HUMAN CELL LINE LC5 AND ITS USE GESELLSCHAFT FÜR STRAHLEN- UND UMWELTFORSCHUNG MIT BESCHRÄNKTER HAFTUNG (GSF) (DE) 1990-11-29 WO disclosed
EP-0258899-A2 Mammalian cell mutagenicity screening test MEDICAL RESEARCH COUNCIL (GB) 1988-03-09 EP disclosed
US-4407943-A SUPPRESSION OF NONSPECIFIC BINDING BY COATING MICROPOROUS MEMBRANE WITH ZEIN OR COLLAGEN MILLIPORE CORPORATION (US) 1983-10-04 US disclosed
EP-0014261-B1 PROCESS FOR THE PREPARATION OF DERIVATIVES OF 3-(4-HYDROXYANILINO)-CARBAZOLE AND THE USE OF THE DERIVATIVES SO OBTAINED IN THE PREPARATION OF SULFUR DYES CASSELLA Aktiengesellschaft (DE) 1982-07-07 EP disclosed
US-4320060-A Process for the preparation of derivatives of 3-(4-hydroxy-anilino)carbazole CASSELLA AKTIENGESELLSCHAFT (DE) 1982-03-16 US disclosed
EP-0014261-A1 Process for the preparation of derivatives of 3-(4-hydroxyanilino)-carbazole and the use of the derivatives so obtained in the preparation of sulfur dyes CASSELLA Aktiengesellschaft (DE) 1980-08-20 EP disclosed